Literature DB >> 5077472

Serum and urine fibrinogen-fibrin-related antigen (F.R.-antigen) levels in renal disease.

J D Briggs, C R Prentice, M M Hutton, A C Kennedy, G P McNicol.   

Abstract

The concentration of serum fibrinogen-fibrin-related antigen (F.R.-antigen) was measured in a group of 142 patients with various renal disorders, in 38 of whom urine F.R.-antigen was also estimated. Raised serum F.R.-antigen levels were present in 48% of the patients, with no particular preponderance in any diagnostic category apart from acute reversible intrinsic renal failure in which high levels were invariably present. Significantly-raised serum levels were also present in the patients with microangiopathic haemolytic anaemia and in those with the more severe degrees of renal impairment. Urine F.R.-antigen was increased in 34 of the 38 patients. The amount of F.R.-antigen in the urine correlated with the degree of proteinuria but not with the serum F.R.-antigen levels. The evidence relating to intravascular coagulation in renal disease is reviewed, and it is suggested that there is a high incidence of localized fibrinogen or fibrin degradation in the kidney, which is related more to factors such as the presence of uraemia and microangiopathic haemolytic anaemia rather than to the diagnostic category.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5077472      PMCID: PMC1786272          DOI: 10.1136/bmj.4.5832.82

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  27 in total

1.  Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury.

Authors:  W E Braun; J P Merrill
Journal:  N Engl J Med       Date:  1968-06-20       Impact factor: 91.245

2.  Study of proteins and fibrinolysis in patients with glomerulonephritis.

Authors:  E N Wardle; I S Menon; S P Rastogi
Journal:  Br Med J       Date:  1970-05-02

3.  Fibrinogen breakdown products: identification and assay in serum and urine.

Authors:  H Rayner; F Parashevas; L G Israels; E D Israels
Journal:  J Lab Clin Med       Date:  1969-10

4.  Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension.

Authors:  A L Linton; H Gavras; R I Gleadle; H E Hutchison; D H Lawson; A F Lever; R F Macadam; G P McNicol; J I Robertson
Journal:  Lancet       Date:  1969-06-28       Impact factor: 79.321

5.  Split products of fibrin in human renal disease.

Authors:  E R Stiehm; C W Trygstad
Journal:  Am J Med       Date:  1969-05       Impact factor: 4.965

6.  The role of fibrinogen in renal disease. I. Production of experimental lesions in mice.

Authors:  L Humair; E V Potter; H C Kwaan
Journal:  J Lab Clin Med       Date:  1969-07

7.  Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus.

Authors:  F Paronetto; D Koffler
Journal:  J Clin Invest       Date:  1965-10       Impact factor: 14.808

8.  The defibrination syndrome: clinical features and laboratory diagnosis.

Authors:  C Merskey; A J Johnson; G J Kleiner; H Wohl
Journal:  Br J Haematol       Date:  1967-07       Impact factor: 6.998

9.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

10.  Fibrin breakdown products and fibrinolysis in renal disease.

Authors:  E N Wardle; G Taylor
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

View more
  3 in total

1.  Conditions for collection of serum samples for the measurement of fibrin(ogen) degradation products by radioimmunoassay of fragment E.

Authors:  M J Martin; Y B Gordon; S M Ratky; L R Baker; T Chard
Journal:  J Clin Pathol       Date:  1976-04       Impact factor: 3.411

2.  Fibrin-fibrinogen degradation products in children with renal disease.

Authors:  W S Uttley; H Maxwell; J D Cash
Journal:  Arch Dis Child       Date:  1974-02       Impact factor: 3.791

3.  Fibrinogen-fibrin degradation product levels in different types of intravascular haemolysis.

Authors:  S D Slater; C R Prentice; W H Bain; J D Briggs
Journal:  Br Med J       Date:  1973-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.